S100A10 and fibrosarcoma: Our initial studies, which were the first to examine cancer cell growth and invasion with the S100A10-knockout mouse, revealed that the growth of murine Lewis lung carcinomas or T241 fibrosarcomas was dramatically reduced in the S100A10-deficient mice compared with wild-type mice [102].